BriaCell Therapeutics Cor... (BCTXW)

0.08

-0.01 (-11.11%)

At close: Apr 21, 2025, 3:18 PM

0.09

12.37%

After-hours: Apr 21, 2025, 04:00 PM EDT

Company Description

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies.

It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor.

It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.

The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT.

BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

BriaCell Therapeutics Corp.

Address: Bellevue Centre West Vancouver, CA
Website	https://briacell.com

Name	Position
Dr. William V. Williams M.D.	Chief Executive Officer, President & Director
Gadi Levin B.Com., C.A., CPA, M.B.A.	Chief Financial Officer & Corporate Secretary
Dr. Charles Louis Wiseman FACP, M.D.	Founder, Principal Research Advisor & Member of Scientific Advisory Board
Dr. Giuseppe Del Priore M.D., M.P.H., MPH	Chief Medical Officer
Dr. Miguel A. Lopez-Lago Ph.D.	Chief Scientific Officer